Cayman

Showing 28051–28200 of 45550 results

  • LUF6283 is a partial agonist of GPR109A/HCA2 G protein-coupled receptors (Ki = 0.55 μM in a radioligand binding assay).{42585} It stimulates [35S]-GTPγS binding and increases phosphorylation of ERK in HEK293T cells expressing GPR109A/HCA2 receptors (EC50s = 3.1 and 0.32 μM, respectively). In vivo, LUF6283 (400 mg/kg per day) reduces plasma levels of VLDL and hepatic expression of apolipoprotein B in mice.  

     

    Brand:
    Cayman
    SKU:-
  • LUF6283 is a partial agonist of GPR109A/HCA2 G protein-coupled receptors (Ki = 0.55 μM in a radioligand binding assay).{42585} It stimulates [35S]-GTPγS binding and increases phosphorylation of ERK in HEK293T cells expressing GPR109A/HCA2 receptors (EC50s = 3.1 and 0.32 μM, respectively). In vivo, LUF6283 (400 mg/kg per day) reduces plasma levels of VLDL and hepatic expression of apolipoprotein B in mice.  

     

    Brand:
    Cayman
    SKU:-
  • LUF6283 is a partial agonist of GPR109A/HCA2 G protein-coupled receptors (Ki = 0.55 μM in a radioligand binding assay).{42585} It stimulates [35S]-GTPγS binding and increases phosphorylation of ERK in HEK293T cells expressing GPR109A/HCA2 receptors (EC50s = 3.1 and 0.32 μM, respectively). In vivo, LUF6283 (400 mg/kg per day) reduces plasma levels of VLDL and hepatic expression of apolipoprotein B in mice.  

     

    Brand:
    Cayman
    SKU:-
  • LUF6283 is a partial agonist of GPR109A/HCA2 G protein-coupled receptors (Ki = 0.55 μM in a radioligand binding assay).{42585} It stimulates [35S]-GTPγS binding and increases phosphorylation of ERK in HEK293T cells expressing GPR109A/HCA2 receptors (EC50s = 3.1 and 0.32 μM, respectively). In vivo, LUF6283 (400 mg/kg per day) reduces plasma levels of VLDL and hepatic expression of apolipoprotein B in mice.  

     

    Brand:
    Cayman
    SKU:-
  • Luffariellolide is a natural sesterterpenoid which reversibly inhibits secretory phospholipase A2 isoforms from bee venom (IC50 = 230 nM) and snake venom, reducing inflammation.{23775} It blocks the production of platelet-activating factor in stimulated neutrophils (IC50 = 5 μM).{23770} Luffariellolide is also a structural mimic of all-trans retinoic acid (RA) and, at 1 μM, acts as an agonist for the RA receptors RAR α, β, and γ but not for other nuclear receptors.{23773} In RA-sensitive cancer cell lines, luffariellolide induces the expression of RAR target genes and inhibits cell growth.{23773} It also inhibits the activation of hypoxia-inducible factor by hypoxia (IC50 = 3.6 μM).{23774}  

     

    Brand:
    Cayman
    SKU:-
  • Luliconazole is a broad spectrum imidazole that is active against various fungi, including Tinea, Candida, Trichophyton, Aspergillus, and Epidermophyton.{40272,40274} It has MIC values of 2.5-20, 0.63-2.5, 31-250, and ≤0.31-0.63 ng/ml for T. mentagrophytes, T. rubrum, C. albicans, and A. fumigatus, respectively, in broth dilution assays. In vitro, luliconazole has a geometric mean MIC value of 2.35 ng/ml against A. terreus, a fungal species responsible for life-threatening invasive aspergillosis in immunocompromised and high-risk patients.{40273} It prevents mortality in rats with systemic A. fumigatus infections and in mice with systemic C. albicans infections.{40274} It is effective in eliminating tinea pedis in a guinea pig model when used topically at a concentration of 1% once per day for seven days.{40272} Topical formulations containing luliconazole have been used in the treatment of fungal infections.  

     

    Brand:
    Cayman
    SKU:23120 - 1 g

    Available on backorder

  • Luliconazole is a broad spectrum imidazole that is active against various fungi, including Tinea, Candida, Trichophyton, Aspergillus, and Epidermophyton.{40272,40274} It has MIC values of 2.5-20, 0.63-2.5, 31-250, and ≤0.31-0.63 ng/ml for T. mentagrophytes, T. rubrum, C. albicans, and A. fumigatus, respectively, in broth dilution assays. In vitro, luliconazole has a geometric mean MIC value of 2.35 ng/ml against A. terreus, a fungal species responsible for life-threatening invasive aspergillosis in immunocompromised and high-risk patients.{40273} It prevents mortality in rats with systemic A. fumigatus infections and in mice with systemic C. albicans infections.{40274} It is effective in eliminating tinea pedis in a guinea pig model when used topically at a concentration of 1% once per day for seven days.{40272} Topical formulations containing luliconazole have been used in the treatment of fungal infections.  

     

    Brand:
    Cayman
    SKU:23120 - 250 mg

    Available on backorder

  • Luliconazole is a broad spectrum imidazole that is active against various fungi, including Tinea, Candida, Trichophyton, Aspergillus, and Epidermophyton.{40272,40274} It has MIC values of 2.5-20, 0.63-2.5, 31-250, and ≤0.31-0.63 ng/ml for T. mentagrophytes, T. rubrum, C. albicans, and A. fumigatus, respectively, in broth dilution assays. In vitro, luliconazole has a geometric mean MIC value of 2.35 ng/ml against A. terreus, a fungal species responsible for life-threatening invasive aspergillosis in immunocompromised and high-risk patients.{40273} It prevents mortality in rats with systemic A. fumigatus infections and in mice with systemic C. albicans infections.{40274} It is effective in eliminating tinea pedis in a guinea pig model when used topically at a concentration of 1% once per day for seven days.{40272} Topical formulations containing luliconazole have been used in the treatment of fungal infections.  

     

    Brand:
    Cayman
    SKU:23120 - 5 g

    Available on backorder

  • Luliconazole is a broad spectrum imidazole that is active against various fungi, including Tinea, Candida, Trichophyton, Aspergillus, and Epidermophyton.{40272,40274} It has MIC values of 2.5-20, 0.63-2.5, 31-250, and ≤0.31-0.63 ng/ml for T. mentagrophytes, T. rubrum, C. albicans, and A. fumigatus, respectively, in broth dilution assays. In vitro, luliconazole has a geometric mean MIC value of 2.35 ng/ml against A. terreus, a fungal species responsible for life-threatening invasive aspergillosis in immunocompromised and high-risk patients.{40273} It prevents mortality in rats with systemic A. fumigatus infections and in mice with systemic C. albicans infections.{40274} It is effective in eliminating tinea pedis in a guinea pig model when used topically at a concentration of 1% once per day for seven days.{40272} Topical formulations containing luliconazole have been used in the treatment of fungal infections.  

     

    Brand:
    Cayman
    SKU:23120 - 500 mg

    Available on backorder

  • Lumefantrine is an antimalarial drug that is used in combination with artemether (Item No. 11815).{26532} The pairing of lumefantrine and artemether is a major form of oral artemisinin combination therapy used against uncomplicated P. falciparum malaria.{28281,21234} Lumefantrine also blocks the rapidly activating delayed-rectifier potassium channel (IKr; IC50 = 8.1 µM).{24505}  

     

    Brand:
    Cayman
    SKU:20678 -

    Available on backorder

  • Lumefantrine is an antimalarial drug that is used in combination with artemether (Item No. 11815).{26532} The pairing of lumefantrine and artemether is a major form of oral artemisinin combination therapy used against uncomplicated P. falciparum malaria.{28281,21234} Lumefantrine also blocks the rapidly activating delayed-rectifier potassium channel (IKr; IC50 = 8.1 µM).{24505}  

     

    Brand:
    Cayman
    SKU:20678 -

    Available on backorder

  • Lumefantrine is an antimalarial drug that is used in combination with artemether (Item No. 11815).{26532} The pairing of lumefantrine and artemether is a major form of oral artemisinin combination therapy used against uncomplicated P. falciparum malaria.{28281,21234} Lumefantrine also blocks the rapidly activating delayed-rectifier potassium channel (IKr; IC50 = 8.1 µM).{24505}  

     

    Brand:
    Cayman
    SKU:20678 -

    Available on backorder

  • Lumefantrine is an antimalarial drug that is used in combination with artemether (Item No. 11815).{26532} The pairing of lumefantrine and artemether is a major form of oral artemisinin combination therapy used against uncomplicated P. falciparum malaria.{28281,21234} Lumefantrine also blocks the rapidly activating delayed-rectifier potassium channel (IKr; IC50 = 8.1 µM).{24505}  

     

    Brand:
    Cayman
    SKU:20678 -

    Available on backorder

  • Lumichrome is a natural metabolite of riboflavin. It can be made by photolysis of riboflavin or it can be produced enzymatically in certain microbes and plants.{34351,34353,34358} Lumichrome produced by Rhizobium and other bacterial species induces major developmental changes in plants at nanomolar concentrations.{34353,34355} Lumichrome can stimulate larval metamorphosis in ascidians and activate the LasR quorum sensing receptor of bacteria.{34356,34357} Lumichrome competitively inhibits the uptake of riboflavin by riboflavin transporters from prokaryotes and eukaryotes.{34352,32833}  

     

    Brand:
    Cayman
    SKU:20730 -

    Available on backorder

  • Lumichrome is a natural metabolite of riboflavin. It can be made by photolysis of riboflavin or it can be produced enzymatically in certain microbes and plants.{34351,34353,34358} Lumichrome produced by Rhizobium and other bacterial species induces major developmental changes in plants at nanomolar concentrations.{34353,34355} Lumichrome can stimulate larval metamorphosis in ascidians and activate the LasR quorum sensing receptor of bacteria.{34356,34357} Lumichrome competitively inhibits the uptake of riboflavin by riboflavin transporters from prokaryotes and eukaryotes.{34352,32833}  

     

    Brand:
    Cayman
    SKU:20730 -

    Available on backorder

  • Lumichrome is a natural metabolite of riboflavin. It can be made by photolysis of riboflavin or it can be produced enzymatically in certain microbes and plants.{34351,34353,34358} Lumichrome produced by Rhizobium and other bacterial species induces major developmental changes in plants at nanomolar concentrations.{34353,34355} Lumichrome can stimulate larval metamorphosis in ascidians and activate the LasR quorum sensing receptor of bacteria.{34356,34357} Lumichrome competitively inhibits the uptake of riboflavin by riboflavin transporters from prokaryotes and eukaryotes.{34352,32833}  

     

    Brand:
    Cayman
    SKU:20730 -

    Available on backorder

  • Lumichrome is a natural metabolite of riboflavin. It can be made by photolysis of riboflavin or it can be produced enzymatically in certain microbes and plants.{34351,34353,34358} Lumichrome produced by Rhizobium and other bacterial species induces major developmental changes in plants at nanomolar concentrations.{34353,34355} Lumichrome can stimulate larval metamorphosis in ascidians and activate the LasR quorum sensing receptor of bacteria.{34356,34357} Lumichrome competitively inhibits the uptake of riboflavin by riboflavin transporters from prokaryotes and eukaryotes.{34352,32833}  

     

    Brand:
    Cayman
    SKU:20730 -

    Available on backorder

  • Lumiflavine is a structural analog of the water-soluble vitamin riboflavin that has been used to study the mechanism of uptake of riboflavin into intestinal epithelial (Caco-2) and human retinal pigment epithelial (hRPE) cells.{32832,32833} It inhibits the uptake of radiolabeled riboflavin approximately 3-fold (at 25 µM) and 30-fold (at 10 µM) in Caco-2 cells and hRPE cells, respectively.{32832,32833}  

     

    Brand:
    Cayman
    SKU:20645 -

    Available on backorder

  • Lumiflavine is a structural analog of the water-soluble vitamin riboflavin that has been used to study the mechanism of uptake of riboflavin into intestinal epithelial (Caco-2) and human retinal pigment epithelial (hRPE) cells.{32832,32833} It inhibits the uptake of radiolabeled riboflavin approximately 3-fold (at 25 µM) and 30-fold (at 10 µM) in Caco-2 cells and hRPE cells, respectively.{32832,32833}  

     

    Brand:
    Cayman
    SKU:20645 -

    Available on backorder

  • Lumiflavine is a structural analog of the water-soluble vitamin riboflavin that has been used to study the mechanism of uptake of riboflavin into intestinal epithelial (Caco-2) and human retinal pigment epithelial (hRPE) cells.{32832,32833} It inhibits the uptake of radiolabeled riboflavin approximately 3-fold (at 25 µM) and 30-fold (at 10 µM) in Caco-2 cells and hRPE cells, respectively.{32832,32833}  

     

    Brand:
    Cayman
    SKU:20645 -

    Available on backorder

  • Lumiflavine is a structural analog of the water-soluble vitamin riboflavin that has been used to study the mechanism of uptake of riboflavin into intestinal epithelial (Caco-2) and human retinal pigment epithelial (hRPE) cells.{32832,32833} It inhibits the uptake of radiolabeled riboflavin approximately 3-fold (at 25 µM) and 30-fold (at 10 µM) in Caco-2 cells and hRPE cells, respectively.{32832,32833}  

     

    Brand:
    Cayman
    SKU:20645 -

    Available on backorder

  • Luminol is a cyclic diacyl hydrazide that exhibits chemiluminescence upon oxidation. For example, HRP, combined with hydrogen peroxide as an activator, causes luminescent peroxidation of luminol.{27587} This reaction can be enhanced by certain phenol derivatives, such as p-substituted phenols.{27586} Luminol can also be oxidized, and chemiluminesce, by compounds containing iron, copper, gold, and cyanide.{27585,24232} The excitation/emission maxima for luminol are 355/411 nm.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Luminol is a cyclic diacyl hydrazide that exhibits chemiluminescence upon oxidation. For example, HRP, combined with hydrogen peroxide as an activator, causes luminescent peroxidation of luminol.{27587} This reaction can be enhanced by certain phenol derivatives, such as p-substituted phenols.{27586} Luminol can also be oxidized, and chemiluminesce, by compounds containing iron, copper, gold, and cyanide.{27585,24232} The excitation/emission maxima for luminol are 355/411 nm.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Luminol is a cyclic diacyl hydrazide that exhibits chemiluminescence upon oxidation. For example, HRP, combined with hydrogen peroxide as an activator, causes luminescent peroxidation of luminol.{27587} This reaction can be enhanced by certain phenol derivatives, such as p-substituted phenols.{27586} Luminol can also be oxidized, and chemiluminesce, by compounds containing iron, copper, gold, and cyanide.{27585,24232} The excitation/emission maxima for luminol are 355/411 nm.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Luminol is a cyclic diacyl hydrazide that exhibits chemiluminescence upon oxidation. For example, HRP, combined with hydrogen peroxide as an activator, causes luminescent peroxidation of luminol.{27587} This reaction can be enhanced by certain phenol derivatives, such as p-substituted phenols.{27586} Luminol can also be oxidized, and chemiluminesce, by compounds containing iron, copper, gold, and cyanide.{27585,24232} The excitation/emission maxima for luminol are 355/411 nm.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • Lumiracoxib is a selective inhibitor of COX-2 with IC50 values of 0.13 and 67 µM for COX-2 and COX-1, respectively, in isolated human whole blood.{45516} It reduces increases in the levels of prostaglandin E2 (PGE2; Item No. 14010) induced by IL-1β in human dermal fibroblasts (IC50 = 0.14 µM), as well as in LPS-stimulated RAW 264.7 cells when used at concentrations ranging from 1 to 100 µM.{45516},{45517} Lumiracoxib (3 and 10 mg/kg) also decreases LPS-induced increases in the levels of PGE2 in a rat model of air pouch inflammation.{45518} It reduces M. tuberculosis-induced increases in hind paw volume and the radiological and histopathological severity of arthritic lesions in a rat model of chronic arthritis when administered at a dose of 2 mg/kg.{45516}  

     

    Brand:
    Cayman
    SKU:27645 - 10 mg

    Available on backorder

  • Lumiracoxib is a selective inhibitor of COX-2 with IC50 values of 0.13 and 67 µM for COX-2 and COX-1, respectively, in isolated human whole blood.{45516} It reduces increases in the levels of prostaglandin E2 (PGE2; Item No. 14010) induced by IL-1β in human dermal fibroblasts (IC50 = 0.14 µM), as well as in LPS-stimulated RAW 264.7 cells when used at concentrations ranging from 1 to 100 µM.{45516},{45517} Lumiracoxib (3 and 10 mg/kg) also decreases LPS-induced increases in the levels of PGE2 in a rat model of air pouch inflammation.{45518} It reduces M. tuberculosis-induced increases in hind paw volume and the radiological and histopathological severity of arthritic lesions in a rat model of chronic arthritis when administered at a dose of 2 mg/kg.{45516}  

     

    Brand:
    Cayman
    SKU:27645 - 100 mg

    Available on backorder

  • Lumiracoxib is a selective inhibitor of COX-2 with IC50 values of 0.13 and 67 µM for COX-2 and COX-1, respectively, in isolated human whole blood.{45516} It reduces increases in the levels of prostaglandin E2 (PGE2; Item No. 14010) induced by IL-1β in human dermal fibroblasts (IC50 = 0.14 µM), as well as in LPS-stimulated RAW 264.7 cells when used at concentrations ranging from 1 to 100 µM.{45516},{45517} Lumiracoxib (3 and 10 mg/kg) also decreases LPS-induced increases in the levels of PGE2 in a rat model of air pouch inflammation.{45518} It reduces M. tuberculosis-induced increases in hind paw volume and the radiological and histopathological severity of arthritic lesions in a rat model of chronic arthritis when administered at a dose of 2 mg/kg.{45516}  

     

    Brand:
    Cayman
    SKU:27645 - 50 mg

    Available on backorder

  • Luotonin A is an alkaloid originally isolated from a plant used in traditional Chinese medicine.{22184} It inhibits the growth of mouse leukemia P388 cells (IC50 = 1.8 μg/ml).{22184} Luotonin A is structurally similar to the alkaloid camptothecin (Item No. 11694) and, like camptothecin, it binds to and stabilizes the topoisomerase I-DNA binary complex, leading to DNA breakage and cell death (IC50 = 5.07-12.6 μM).{25352} Also like camptothecin, luotonin A forms non-covalent complexes with double-stranded DNA in the minor groove and this association can be followed by native fluorescence associated with the aromatic and heterocyclic ring structure.{25350} Luotonin A also selectively inhibits the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 (IC50 = ~6 μM for each) in human liver microsomes.{25351}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin A is an alkaloid originally isolated from a plant used in traditional Chinese medicine.{22184} It inhibits the growth of mouse leukemia P388 cells (IC50 = 1.8 μg/ml).{22184} Luotonin A is structurally similar to the alkaloid camptothecin (Item No. 11694) and, like camptothecin, it binds to and stabilizes the topoisomerase I-DNA binary complex, leading to DNA breakage and cell death (IC50 = 5.07-12.6 μM).{25352} Also like camptothecin, luotonin A forms non-covalent complexes with double-stranded DNA in the minor groove and this association can be followed by native fluorescence associated with the aromatic and heterocyclic ring structure.{25350} Luotonin A also selectively inhibits the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 (IC50 = ~6 μM for each) in human liver microsomes.{25351}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin A is an alkaloid originally isolated from a plant used in traditional Chinese medicine.{22184} It inhibits the growth of mouse leukemia P388 cells (IC50 = 1.8 μg/ml).{22184} Luotonin A is structurally similar to the alkaloid camptothecin (Item No. 11694) and, like camptothecin, it binds to and stabilizes the topoisomerase I-DNA binary complex, leading to DNA breakage and cell death (IC50 = 5.07-12.6 μM).{25352} Also like camptothecin, luotonin A forms non-covalent complexes with double-stranded DNA in the minor groove and this association can be followed by native fluorescence associated with the aromatic and heterocyclic ring structure.{25350} Luotonin A also selectively inhibits the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 (IC50 = ~6 μM for each) in human liver microsomes.{25351}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin A is an alkaloid originally isolated from a plant used in traditional Chinese medicine.{22184} It inhibits the growth of mouse leukemia P388 cells (IC50 = 1.8 μg/ml).{22184} Luotonin A is structurally similar to the alkaloid camptothecin (Item No. 11694) and, like camptothecin, it binds to and stabilizes the topoisomerase I-DNA binary complex, leading to DNA breakage and cell death (IC50 = 5.07-12.6 μM).{25352} Also like camptothecin, luotonin A forms non-covalent complexes with double-stranded DNA in the minor groove and this association can be followed by native fluorescence associated with the aromatic and heterocyclic ring structure.{25350} Luotonin A also selectively inhibits the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 (IC50 = ~6 μM for each) in human liver microsomes.{25351}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin A is an alkaloid originally isolated from a plant used in traditional Chinese medicine.{22184} It inhibits the growth of mouse leukemia P388 cells (IC50 = 1.8 μg/ml).{22184} Luotonin A is structurally similar to the alkaloid camptothecin (Item No. 11694) and, like camptothecin, it binds to and stabilizes the topoisomerase I-DNA binary complex, leading to DNA breakage and cell death (IC50 = 5.07-12.6 μM).{25352} Also like camptothecin, luotonin A forms non-covalent complexes with double-stranded DNA in the minor groove and this association can be followed by native fluorescence associated with the aromatic and heterocyclic ring structure.{25350} Luotonin A also selectively inhibits the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 (IC50 = ~6 μM for each) in human liver microsomes.{25351}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge, a plant used in traditional Chinese medicine for the treatment of rheumatism and various other inflammatory conditions.{22184} It demonstrates cytotoxicity against leukemia P-388 cells (IC50 = 2.3 µM) through a mechanism that involves stabilizing the DNA topoisomerase I-DNA complex.{22184,25352,25350}  

     

    Brand:
    Cayman
    SKU:-
  • Lupeol, a dietary triterpene found in certain fruits, vegetables, and medicinal plants, has potent anti-inflammatory, anticarcinogenic, antimutagenic, and antimalarial activity. It suppresses the growth of hepatocellular carcinoma cell lines SMMC7721 and HepG2 with IC50 values of 45 and 48.5 μM and melanoma cell lines Mel 928 and Mel 1241 with IC50 values of 75 and 72 μM.{20463,20465} At 0.76 g/kg lupeol causes a significant decrease in the blood pressure of stroke-prone hypertensive rats and reduces expression of hepatic genes involved in triglyceride and cholesterol synthesis.{20464} It also has significant anti-inflammatory effects at 50 mg/kg in a carrageenan-induced edema model, inhibiting neutrophil migration.{20466}  

     

    Brand:
    Cayman
    SKU:11215 - 10 mg

    Available on backorder

  • Lupeol, a dietary triterpene found in certain fruits, vegetables, and medicinal plants, has potent anti-inflammatory, anticarcinogenic, antimutagenic, and antimalarial activity. It suppresses the growth of hepatocellular carcinoma cell lines SMMC7721 and HepG2 with IC50 values of 45 and 48.5 μM and melanoma cell lines Mel 928 and Mel 1241 with IC50 values of 75 and 72 μM.{20463,20465} At 0.76 g/kg lupeol causes a significant decrease in the blood pressure of stroke-prone hypertensive rats and reduces expression of hepatic genes involved in triglyceride and cholesterol synthesis.{20464} It also has significant anti-inflammatory effects at 50 mg/kg in a carrageenan-induced edema model, inhibiting neutrophil migration.{20466}  

     

    Brand:
    Cayman
    SKU:11215 - 25 mg

    Available on backorder

  • Lupeol, a dietary triterpene found in certain fruits, vegetables, and medicinal plants, has potent anti-inflammatory, anticarcinogenic, antimutagenic, and antimalarial activity. It suppresses the growth of hepatocellular carcinoma cell lines SMMC7721 and HepG2 with IC50 values of 45 and 48.5 μM and melanoma cell lines Mel 928 and Mel 1241 with IC50 values of 75 and 72 μM.{20463,20465} At 0.76 g/kg lupeol causes a significant decrease in the blood pressure of stroke-prone hypertensive rats and reduces expression of hepatic genes involved in triglyceride and cholesterol synthesis.{20464} It also has significant anti-inflammatory effects at 50 mg/kg in a carrageenan-induced edema model, inhibiting neutrophil migration.{20466}  

     

    Brand:
    Cayman
    SKU:11215 - 5 mg

    Available on backorder

  • Lupulone is a beta-acid that has been found in the hop plant, H. lupulus, and has diverse biological activities, including antibacterial, antioxidant, and anticarcinogenic properties.{45412,45413,45416} Lupulone is active against B. subtilis and S. aureus (MICs = 1 and 1.2 µg/ml, respectively), as well as T. b. brucei and L. m. mexicana (IC50s = 0.9 and 4.7 µg/ml, respectively).{45412,45413} It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals in a cell-free assay and inhibits lipid peroxidation in rat brain homogenates (IC50s = 25 and 39 µM, respectively).{45414} It reduces proliferation, migration, and capillary tube formation in human umbilical vein endothelial cells (HUVECs) when used at concentrations ranging from 2.5 to 50 µg/ml.{45415} Lupulone (40 µg/ml) activates the extrinsic apoptotic death pathway in SW480 and SW620 colon cancer cells.{45416}  

     

    Brand:
    Cayman
    SKU:28481 - 1 mg

    Available on backorder

  • Lupulone is a beta-acid that has been found in the hop plant, H. lupulus, and has diverse biological activities, including antibacterial, antioxidant, and anticarcinogenic properties.{45412,45413,45416} Lupulone is active against B. subtilis and S. aureus (MICs = 1 and 1.2 µg/ml, respectively), as well as T. b. brucei and L. m. mexicana (IC50s = 0.9 and 4.7 µg/ml, respectively).{45412,45413} It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals in a cell-free assay and inhibits lipid peroxidation in rat brain homogenates (IC50s = 25 and 39 µM, respectively).{45414} It reduces proliferation, migration, and capillary tube formation in human umbilical vein endothelial cells (HUVECs) when used at concentrations ranging from 2.5 to 50 µg/ml.{45415} Lupulone (40 µg/ml) activates the extrinsic apoptotic death pathway in SW480 and SW620 colon cancer cells.{45416}  

     

    Brand:
    Cayman
    SKU:28481 - 10 mg

    Available on backorder

  • Lupulone is a beta-acid that has been found in the hop plant, H. lupulus, and has diverse biological activities, including antibacterial, antioxidant, and anticarcinogenic properties.{45412,45413,45416} Lupulone is active against B. subtilis and S. aureus (MICs = 1 and 1.2 µg/ml, respectively), as well as T. b. brucei and L. m. mexicana (IC50s = 0.9 and 4.7 µg/ml, respectively).{45412,45413} It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals in a cell-free assay and inhibits lipid peroxidation in rat brain homogenates (IC50s = 25 and 39 µM, respectively).{45414} It reduces proliferation, migration, and capillary tube formation in human umbilical vein endothelial cells (HUVECs) when used at concentrations ranging from 2.5 to 50 µg/ml.{45415} Lupulone (40 µg/ml) activates the extrinsic apoptotic death pathway in SW480 and SW620 colon cancer cells.{45416}  

     

    Brand:
    Cayman
    SKU:28481 - 5 mg

    Available on backorder

  • Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and α2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively).{42146} In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in step-through latency and passive avoidance in a foot shock test induced by MK-801 (Item No. 10009019) in rats. It reverses MK-801-induced learning impairment in the Morris water maze as well as reference and working memory impairment in the radial arm maze in rats.{42147} Lurasidone also decreases immobility in the tail suspension and forced swim tests, indicating antidepressant-like activity in mice.{42148} Formulations containing lurasidone have been used in the treatment of schizophrenia and mood disorders.  

     

    Brand:
    Cayman
    SKU:9000570 - 1 mg

    Available on backorder

  • Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and α2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively).{42146} In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in step-through latency and passive avoidance in a foot shock test induced by MK-801 (Item No. 10009019) in rats. It reverses MK-801-induced learning impairment in the Morris water maze as well as reference and working memory impairment in the radial arm maze in rats.{42147} Lurasidone also decreases immobility in the tail suspension and forced swim tests, indicating antidepressant-like activity in mice.{42148} Formulations containing lurasidone have been used in the treatment of schizophrenia and mood disorders.  

     

    Brand:
    Cayman
    SKU:9000570 - 10 mg

    Available on backorder

  • Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and α2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively).{42146} In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in step-through latency and passive avoidance in a foot shock test induced by MK-801 (Item No. 10009019) in rats. It reverses MK-801-induced learning impairment in the Morris water maze as well as reference and working memory impairment in the radial arm maze in rats.{42147} Lurasidone also decreases immobility in the tail suspension and forced swim tests, indicating antidepressant-like activity in mice.{42148} Formulations containing lurasidone have been used in the treatment of schizophrenia and mood disorders.  

     

    Brand:
    Cayman
    SKU:9000570 - 25 mg

    Available on backorder

  • Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and α2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively).{42146} In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in step-through latency and passive avoidance in a foot shock test induced by MK-801 (Item No. 10009019) in rats. It reverses MK-801-induced learning impairment in the Morris water maze as well as reference and working memory impairment in the radial arm maze in rats.{42147} Lurasidone also decreases immobility in the tail suspension and forced swim tests, indicating antidepressant-like activity in mice.{42148} Formulations containing lurasidone have been used in the treatment of schizophrenia and mood disorders.  

     

    Brand:
    Cayman
    SKU:9000570 - 5 mg

    Available on backorder

  • Lurasidone metabolite 14283 is an active metabolite of the atypical antipsychotic lurasidone (Item No. 9000570).{43587}  

     

    Brand:
    Cayman
    SKU:26651 - 1 mg

    Available on backorder

  • Lurasidone metabolite 14326 is an active metabolite of the atypical antipsychotic lurasidone (Item No. 9000570).{49005}  

     

    Brand:
    Cayman
    SKU:26652 - 1 mg

    Available on backorder

  • Lurasidone metabolite 14326 is an active metabolite of the atypical antipsychotic lurasidone (Item No. 9000570).{49005}  

     

    Brand:
    Cayman
    SKU:26652 - 500 µg

    Available on backorder

  • Lurasidone-d8 is intended for use as an internal standard for the quantification of lurasidone (Item No. 9000570) by GC- or LC-MS. Lurasidone is an atypical antipsychotic that binds to dopamine D2, serotonin (5-HT) receptor subtypes 5-HT2A, 5-HT1A, and 5-HT7, and α2C-adrenergic receptors (Kis = 1.68, 2.03, 6.75, 0.495, and 10.8 nM, respectively).{42146} In vivo, pre-training administration of lurasidone (1 and 3 mg/kg) reverses impairment in step-through latency and passive avoidance in a foot shock test induced by MK-801 (Item No. 10009019) in rats. It reverses MK-801-induced learning impairment in the Morris water maze as well as reference and working memory impairment in the radial arm maze in rats.{42147} Lurasidone also decreases immobility in the tail suspension and forced swim tests, indicating antidepressant-like activity in mice.{42148} Formulations containing lurasidone have been used in the treatment of schizophrenia and mood disorders.  

     

    Brand:
    Cayman
    SKU:25222 - 1 mg

    Available on backorder

  • Lusutrombopag is an agonist of the thrombopoietin receptor.{45125} It induces proliferation of Ba/F3 cells expressing human MPL, the gene for the thrombopoietin receptor, with an EC50 value of 84 nM but not of those expressing mouse Mpl.{45126} Lusutrombopag (0.3-10 mg/kg per day) increases the number of circulating platelets in a transgenic mouse model expressing human MPL and increases the number of megakaryocytes in the bone marrow when administered at a dose of 10 mg/kg per day. Formulations containing lusutrombopag have been used in the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo invasive procedures.  

     

    Brand:
    Cayman
    SKU:26533 - 1 mg

    Available on backorder

  • Lusutrombopag is an agonist of the thrombopoietin receptor.{45125} It induces proliferation of Ba/F3 cells expressing human MPL, the gene for the thrombopoietin receptor, with an EC50 value of 84 nM but not of those expressing mouse Mpl.{45126} Lusutrombopag (0.3-10 mg/kg per day) increases the number of circulating platelets in a transgenic mouse model expressing human MPL and increases the number of megakaryocytes in the bone marrow when administered at a dose of 10 mg/kg per day. Formulations containing lusutrombopag have been used in the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo invasive procedures.  

     

    Brand:
    Cayman
    SKU:26533 - 10 mg

    Available on backorder

  • Lusutrombopag is an agonist of the thrombopoietin receptor.{45125} It induces proliferation of Ba/F3 cells expressing human MPL, the gene for the thrombopoietin receptor, with an EC50 value of 84 nM but not of those expressing mouse Mpl.{45126} Lusutrombopag (0.3-10 mg/kg per day) increases the number of circulating platelets in a transgenic mouse model expressing human MPL and increases the number of megakaryocytes in the bone marrow when administered at a dose of 10 mg/kg per day. Formulations containing lusutrombopag have been used in the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo invasive procedures.  

     

    Brand:
    Cayman
    SKU:26533 - 5 mg

    Available on backorder

  • Lusutrombopag is an agonist of the thrombopoietin receptor.{45125} It induces proliferation of Ba/F3 cells expressing human MPL, the gene for the thrombopoietin receptor, with an EC50 value of 84 nM but not of those expressing mouse Mpl.{45126} Lusutrombopag (0.3-10 mg/kg per day) increases the number of circulating platelets in a transgenic mouse model expressing human MPL and increases the number of megakaryocytes in the bone marrow when administered at a dose of 10 mg/kg per day. Formulations containing lusutrombopag have been used in the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo invasive procedures.  

     

    Brand:
    Cayman
    SKU:26533 - 50 mg

    Available on backorder

  • Lutein is a dietary carotenoid that has been found in eggs and yellow-colored fruits and vegetables and has diverse biological activities.{56228,56230,56229,56231} It reduces hyperglycemia-induced mitochondrial DNA damage and production of reactive oxygen species (ROS) and promotes mitochondrial biogenesis in ARPE-19 cells when used at a concentration of 10 µM.{56228} Lutein (20 mg/kg) increases nitric oxide (NO) production and decreases serum levels of endothelin-1 (Item No. 24127) in a rat model of hyperhomocysteinemia.{56230} Dietary administration of lutein (0.2%) decreases monocyte migration and lesion size in an ApoE-/- and Ldlr-/- mouse models of atherosclerosis. Lutein reduces infarct size and cardiac malondialdehyde (MDA), lactate dehydrogenase (LDH), and troponin T levels, and increases cardiac levels of catalase (CAT), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and Nrf2 in a rat model of heart failure induced by isoproterenol (Item No. 15592).{56229} It forms a retinal pigment in human eyes, and high dietary intake of lutein is positively correlated with reduced risk of age-related macular degeneration and cataracts in humans.{56231}  

     

    Brand:
    Cayman
    SKU:10010811 - 1 mg

    Available on backorder

  • Lutein is a dietary carotenoid that has been found in eggs and yellow-colored fruits and vegetables and has diverse biological activities.{56228,56230,56229,56231} It reduces hyperglycemia-induced mitochondrial DNA damage and production of reactive oxygen species (ROS) and promotes mitochondrial biogenesis in ARPE-19 cells when used at a concentration of 10 µM.{56228} Lutein (20 mg/kg) increases nitric oxide (NO) production and decreases serum levels of endothelin-1 (Item No. 24127) in a rat model of hyperhomocysteinemia.{56230} Dietary administration of lutein (0.2%) decreases monocyte migration and lesion size in an ApoE-/- and Ldlr-/- mouse models of atherosclerosis. Lutein reduces infarct size and cardiac malondialdehyde (MDA), lactate dehydrogenase (LDH), and troponin T levels, and increases cardiac levels of catalase (CAT), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and Nrf2 in a rat model of heart failure induced by isoproterenol (Item No. 15592).{56229} It forms a retinal pigment in human eyes, and high dietary intake of lutein is positively correlated with reduced risk of age-related macular degeneration and cataracts in humans.{56231}  

     

    Brand:
    Cayman
    SKU:10010811 - 10 mg

    Available on backorder

  • Lutein is a dietary carotenoid that has been found in eggs and yellow-colored fruits and vegetables and has diverse biological activities.{56228,56230,56229,56231} It reduces hyperglycemia-induced mitochondrial DNA damage and production of reactive oxygen species (ROS) and promotes mitochondrial biogenesis in ARPE-19 cells when used at a concentration of 10 µM.{56228} Lutein (20 mg/kg) increases nitric oxide (NO) production and decreases serum levels of endothelin-1 (Item No. 24127) in a rat model of hyperhomocysteinemia.{56230} Dietary administration of lutein (0.2%) decreases monocyte migration and lesion size in an ApoE-/- and Ldlr-/- mouse models of atherosclerosis. Lutein reduces infarct size and cardiac malondialdehyde (MDA), lactate dehydrogenase (LDH), and troponin T levels, and increases cardiac levels of catalase (CAT), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and Nrf2 in a rat model of heart failure induced by isoproterenol (Item No. 15592).{56229} It forms a retinal pigment in human eyes, and high dietary intake of lutein is positively correlated with reduced risk of age-related macular degeneration and cataracts in humans.{56231}  

     

    Brand:
    Cayman
    SKU:10010811 - 25 mg

    Available on backorder

  • Lutein is a dietary carotenoid that has been found in eggs and yellow-colored fruits and vegetables and has diverse biological activities.{56228,56230,56229,56231} It reduces hyperglycemia-induced mitochondrial DNA damage and production of reactive oxygen species (ROS) and promotes mitochondrial biogenesis in ARPE-19 cells when used at a concentration of 10 µM.{56228} Lutein (20 mg/kg) increases nitric oxide (NO) production and decreases serum levels of endothelin-1 (Item No. 24127) in a rat model of hyperhomocysteinemia.{56230} Dietary administration of lutein (0.2%) decreases monocyte migration and lesion size in an ApoE-/- and Ldlr-/- mouse models of atherosclerosis. Lutein reduces infarct size and cardiac malondialdehyde (MDA), lactate dehydrogenase (LDH), and troponin T levels, and increases cardiac levels of catalase (CAT), superoxide dismutase (SOD), heme oxygenase-1 (HO-1), and Nrf2 in a rat model of heart failure induced by isoproterenol (Item No. 15592).{56229} It forms a retinal pigment in human eyes, and high dietary intake of lutein is positively correlated with reduced risk of age-related macular degeneration and cataracts in humans.{56231}  

     

    Brand:
    Cayman
    SKU:10010811 - 5 mg

    Available on backorder

  • Luteinizing hormone (LH) is a glycoprotein produced by the pituitary gland and consists of two subunits with a total molecular mass of approximately 30 kDa. The α-subunit is identical to the α-subunit of other pituitary hormones, such follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), and chorionic gonadotropin (hCG). The β-subunit is unique to LH and confers the specific biological activity to the molecule. Luteinizing hormone stimulates ovulation and the development of the corpus luteum, and maintains the function of the corpus luteum during the first two weeks of pregnancy. In males, LH stimulates the production of testosterone by the testis. Cayman’s Luteinizing Hormone ELISA (human) Kit is an immunometric (i.e., sandwich) ELISA which can be used to measure luteinizing hormone within the range of 0.5-200 mIU/ml. This assay offers specific and sensitive analysis of LH in human serum and has not been validated for other types of samples.  

     

    Brand:
    Cayman
    SKU:500720 - 96 wells

    Available on backorder

  • Luteolin is a polyphenolic flavone found in many plants including soybeans and perilla leaves.{11740} Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM.{11260} Luteolin has also been found to inhibit the release of TNFα from neutrophils, and to inhibit matrix metalloproteinases.{11743}  

     

    Brand:
    Cayman
    SKU:10004161 - 10 mg

    Available on backorder

  • Luteolin is a polyphenolic flavone found in many plants including soybeans and perilla leaves.{11740} Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM.{11260} Luteolin has also been found to inhibit the release of TNFα from neutrophils, and to inhibit matrix metalloproteinases.{11743}  

     

    Brand:
    Cayman
    SKU:10004161 - 100 mg

    Available on backorder

  • Luteolin is a polyphenolic flavone found in many plants including soybeans and perilla leaves.{11740} Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM.{11260} Luteolin has also been found to inhibit the release of TNFα from neutrophils, and to inhibit matrix metalloproteinases.{11743}  

     

    Brand:
    Cayman
    SKU:10004161 - 50 mg

    Available on backorder

  • Luteolin is a polyphenolic flavone found in many plants including soybeans and perilla leaves.{11740} Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM.{11260} Luteolin has also been found to inhibit the release of TNFα from neutrophils, and to inhibit matrix metalloproteinases.{11743}  

     

    Brand:
    Cayman
    SKU:10004161 - 500 mg

    Available on backorder

  • Luteoreticulin is a nitro-containing bacterial metabolite originally isolated from S. luteoreticuli.{43157} It has mosquitocidal activity against A. aegypti when used at a concentration of 6.25 mg/L and nematocidal activity against C. elegans.{43156}  

     

    Brand:
    Cayman
    SKU:25515 - 2.5 mg

    Available on backorder

  • Luteoreticulin is a nitro-containing bacterial metabolite originally isolated from S. luteoreticuli.{43157} It has mosquitocidal activity against A. aegypti when used at a concentration of 6.25 mg/L and nematocidal activity against C. elegans.{43156}  

     

    Brand:
    Cayman
    SKU:25515 - 500 µg

    Available on backorder

  • In addition to intrinsic antioxidant activities, melatonin (Item No. 14427) evokes its effects through the G protein-coupled receptors MT1A (MT1) and MT1B (MT2).{26016} Luzindole is a melatonin receptor antagonist that preferentially targets MT1B over MT1A (Ki values are = 10-27 and 158-513 nM, respectively).{26020,26015,26017} Luzindole is used both in vitro and in vivo to evaluate the roles of melatonin receptor signaling in diverse pathways, including circadian rhythms, animal behavior, and melanophore response.{26018,26019,26020}  

     

    Brand:
    Cayman
    SKU:-
  • In addition to intrinsic antioxidant activities, melatonin (Item No. 14427) evokes its effects through the G protein-coupled receptors MT1A (MT1) and MT1B (MT2).{26016} Luzindole is a melatonin receptor antagonist that preferentially targets MT1B over MT1A (Ki values are = 10-27 and 158-513 nM, respectively).{26020,26015,26017} Luzindole is used both in vitro and in vivo to evaluate the roles of melatonin receptor signaling in diverse pathways, including circadian rhythms, animal behavior, and melanophore response.{26018,26019,26020}  

     

    Brand:
    Cayman
    SKU:-
  • In addition to intrinsic antioxidant activities, melatonin (Item No. 14427) evokes its effects through the G protein-coupled receptors MT1A (MT1) and MT1B (MT2).{26016} Luzindole is a melatonin receptor antagonist that preferentially targets MT1B over MT1A (Ki values are = 10-27 and 158-513 nM, respectively).{26020,26015,26017} Luzindole is used both in vitro and in vivo to evaluate the roles of melatonin receptor signaling in diverse pathways, including circadian rhythms, animal behavior, and melanophore response.{26018,26019,26020}  

     

    Brand:
    Cayman
    SKU:-
  • In addition to intrinsic antioxidant activities, melatonin (Item No. 14427) evokes its effects through the G protein-coupled receptors MT1A (MT1) and MT1B (MT2).{26016} Luzindole is a melatonin receptor antagonist that preferentially targets MT1B over MT1A (Ki values are = 10-27 and 158-513 nM, respectively).{26020,26015,26017} Luzindole is used both in vitro and in vivo to evaluate the roles of melatonin receptor signaling in diverse pathways, including circadian rhythms, animal behavior, and melanophore response.{26018,26019,26020}  

     

    Brand:
    Cayman
    SKU:-
  • Luzopeptin A is a cyclic depsipeptide antibiotic first isolated from an actinomycete strain.{29678,29676} It displays antitumor activity, as it is highly active in mice against a variety of experimental tumors.{29678} Luzopeptin A acts as a bifunctional DNA intercalator that strongly binds DNA and forms crosslinks between DNA molecules.{29675} It also inhibits reverse transcriptases from HIV-1 and HIV-2 (IC50s = 7 and 68 nM, respectively), as well as cellular DNA polymerases.{29677,29679}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Luzopeptin A is a cyclic depsipeptide antibiotic first isolated from an actinomycete strain.{29678,29676} It displays antitumor activity, as it is highly active in mice against a variety of experimental tumors.{29678} Luzopeptin A acts as a bifunctional DNA intercalator that strongly binds DNA and forms crosslinks between DNA molecules.{29675} It also inhibits reverse transcriptases from HIV-1 and HIV-2 (IC50s = 7 and 68 nM, respectively), as well as cellular DNA polymerases.{29677,29679}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • LX2343 is an inhibitor of β-site amyloid protein cleaving enzyme 1 (BACE1/β-secretase; IC50 = 11.43 μM) and PI3K (IC50 = 15.99 μM).{47505} It inhibits accumulation of Aβ (1-40) (Aβ40) and Aβ42 induced by streptozotocin (STZ; Item No. 13104) in both HEK293-APPSW and CHO-APP cells, which express mutant and wild-type amyloid precursor protein (APP), respectively, in a concentration-dependent manner. It also inhibits STZ-induced increases in JNK and APPThr668 phosphorylation as well as soluble APPβ (sAPPβ) protein levels. LX2343 (10 mg/kg per day) reduces levels of Aβ40 and Aβ42, as well as thioflavine S staining, in the cortex and hippocampus in the APP/PS1 transgenic mouse model of Alzheimer’s disease. It also reduces cortical levels of PI3K, Akt, and mTOR phosphorylation and accumulation of the autophagy substrate p62, indicating increased autophagy. LX2343 (10 mg/kg per day) decreases path length and escape latency time in the Morris water maze in APP/PS1 mice.  

     

    Brand:
    Cayman
    SKU:27799 - 1 mg

    Available on backorder

  • LX2343 is an inhibitor of β-site amyloid protein cleaving enzyme 1 (BACE1/β-secretase; IC50 = 11.43 μM) and PI3K (IC50 = 15.99 μM).{47505} It inhibits accumulation of Aβ (1-40) (Aβ40) and Aβ42 induced by streptozotocin (STZ; Item No. 13104) in both HEK293-APPSW and CHO-APP cells, which express mutant and wild-type amyloid precursor protein (APP), respectively, in a concentration-dependent manner. It also inhibits STZ-induced increases in JNK and APPThr668 phosphorylation as well as soluble APPβ (sAPPβ) protein levels. LX2343 (10 mg/kg per day) reduces levels of Aβ40 and Aβ42, as well as thioflavine S staining, in the cortex and hippocampus in the APP/PS1 transgenic mouse model of Alzheimer’s disease. It also reduces cortical levels of PI3K, Akt, and mTOR phosphorylation and accumulation of the autophagy substrate p62, indicating increased autophagy. LX2343 (10 mg/kg per day) decreases path length and escape latency time in the Morris water maze in APP/PS1 mice.  

     

    Brand:
    Cayman
    SKU:27799 - 10 mg

    Available on backorder

  • LX2343 is an inhibitor of β-site amyloid protein cleaving enzyme 1 (BACE1/β-secretase; IC50 = 11.43 μM) and PI3K (IC50 = 15.99 μM).{47505} It inhibits accumulation of Aβ (1-40) (Aβ40) and Aβ42 induced by streptozotocin (STZ; Item No. 13104) in both HEK293-APPSW and CHO-APP cells, which express mutant and wild-type amyloid precursor protein (APP), respectively, in a concentration-dependent manner. It also inhibits STZ-induced increases in JNK and APPThr668 phosphorylation as well as soluble APPβ (sAPPβ) protein levels. LX2343 (10 mg/kg per day) reduces levels of Aβ40 and Aβ42, as well as thioflavine S staining, in the cortex and hippocampus in the APP/PS1 transgenic mouse model of Alzheimer’s disease. It also reduces cortical levels of PI3K, Akt, and mTOR phosphorylation and accumulation of the autophagy substrate p62, indicating increased autophagy. LX2343 (10 mg/kg per day) decreases path length and escape latency time in the Morris water maze in APP/PS1 mice.  

     

    Brand:
    Cayman
    SKU:27799 - 5 mg

    Available on backorder

  • LX7101 is a potent inhibitor of LIM kinase (LIMK) 1 and 2 and Rho-associated kinase 1 (ROCK-1) and ROCK-2 with IC50 values of 32, 4.3, 69, and 32 nM, respectively.{38221} It is selective, showing no cross reactivity in a panel of binding assays including 78 receptors and transporters and 430 additional kinases, at a concentration of 10 μM. Topical administration (3 μl of 1 mg/ml solution) of LX7101 to the eye reduces intraocular pressure in a dexamethasone-induced mouse model of glaucoma.  

     

    Brand:
    Cayman
    SKU:21209 -

    Out of stock

  • LX7101 is a potent inhibitor of LIM kinase (LIMK) 1 and 2 and Rho-associated kinase 1 (ROCK-1) and ROCK-2 with IC50 values of 32, 4.3, 69, and 32 nM, respectively.{38221} It is selective, showing no cross reactivity in a panel of binding assays including 78 receptors and transporters and 430 additional kinases, at a concentration of 10 μM. Topical administration (3 μl of 1 mg/ml solution) of LX7101 to the eye reduces intraocular pressure in a dexamethasone-induced mouse model of glaucoma.  

     

    Brand:
    Cayman
    SKU:21209 -

    Out of stock

  • LX7101 is a potent inhibitor of LIM kinase (LIMK) 1 and 2 and Rho-associated kinase 1 (ROCK-1) and ROCK-2 with IC50 values of 32, 4.3, 69, and 32 nM, respectively.{38221} It is selective, showing no cross reactivity in a panel of binding assays including 78 receptors and transporters and 430 additional kinases, at a concentration of 10 μM. Topical administration (3 μl of 1 mg/ml solution) of LX7101 to the eye reduces intraocular pressure in a dexamethasone-induced mouse model of glaucoma.  

     

    Brand:
    Cayman
    SKU:21209 -

    Out of stock

  • LXH254 is a pan-RAF inhibitor that selectively inhibits B-RAF and C-RAF over a panel of 456 human kinases.{46358} It inhibits MAPK signaling in tumor cells expressing mutant B-RAFV600. LXH254 induces tumor regression in various mouse xenograft models.  

     

    Brand:
    Cayman
    SKU:28231 - 1 mg

    Available on backorder

  • LXH254 is a pan-RAF inhibitor that selectively inhibits B-RAF and C-RAF over a panel of 456 human kinases.{46358} It inhibits MAPK signaling in tumor cells expressing mutant B-RAFV600. LXH254 induces tumor regression in various mouse xenograft models.  

     

    Brand:
    Cayman
    SKU:28231 - 10 mg

    Available on backorder

  • LXH254 is a pan-RAF inhibitor that selectively inhibits B-RAF and C-RAF over a panel of 456 human kinases.{46358} It inhibits MAPK signaling in tumor cells expressing mutant B-RAFV600. LXH254 induces tumor regression in various mouse xenograft models.  

     

    Brand:
    Cayman
    SKU:28231 - 25 mg

    Available on backorder

  • LXH254 is a pan-RAF inhibitor that selectively inhibits B-RAF and C-RAF over a panel of 456 human kinases.{46358} It inhibits MAPK signaling in tumor cells expressing mutant B-RAFV600. LXH254 induces tumor regression in various mouse xenograft models.  

     

    Brand:
    Cayman
    SKU:28231 - 5 mg

    Available on backorder

  • LXR-623 is a liver X receptor (LXR) modulator that acts as a partial agonist at LXRα and a full agonist at LXRβ (IC50s = 179 and 24 nM, respectively).{33455,32907} It is orally bioavailable and readily passes the blood-brain barrier.{33455,32907,32909} LXR-623 is anti-atherogenic in animal models of atherosclerosis, showing synergistic effects when combined with simvastatin (Item Nos. 10010344 | 10010345).{33455,33456,32907}  

     

    Brand:
    Cayman
    SKU:21117 -

    Out of stock

  • LXR-623 is a liver X receptor (LXR) modulator that acts as a partial agonist at LXRα and a full agonist at LXRβ (IC50s = 179 and 24 nM, respectively).{33455,32907} It is orally bioavailable and readily passes the blood-brain barrier.{33455,32907,32909} LXR-623 is anti-atherogenic in animal models of atherosclerosis, showing synergistic effects when combined with simvastatin (Item Nos. 10010344 | 10010345).{33455,33456,32907}  

     

    Brand:
    Cayman
    SKU:21117 -

    Out of stock

  • LXR-623 is a liver X receptor (LXR) modulator that acts as a partial agonist at LXRα and a full agonist at LXRβ (IC50s = 179 and 24 nM, respectively).{33455,32907} It is orally bioavailable and readily passes the blood-brain barrier.{33455,32907,32909} LXR-623 is anti-atherogenic in animal models of atherosclerosis, showing synergistic effects when combined with simvastatin (Item Nos. 10010344 | 10010345).{33455,33456,32907}  

     

    Brand:
    Cayman
    SKU:21117 -

    Out of stock

  • LXS-196 is a PKC inhibitor (IC50s = 1.9 and 0.4 nM for PKCα and PKCθ, respectively).{52782} It is selective for PKCα and PKCθ over GSK3β (IC50 = 3,100 nM). It inhibits proliferation of TMD8 B cell lymphoma and 92.1 uveal melanoma cells (IC50s = 900 and 184 nM, respectively) but not SK-MEL-28 skin melanoma cells (IC50 = >10,000 nM).  

     

    Brand:
    Cayman
    SKU:31455 - 1 mg

    Available on backorder

  • LXS-196 is a PKC inhibitor (IC50s = 1.9 and 0.4 nM for PKCα and PKCθ, respectively).{52782} It is selective for PKCα and PKCθ over GSK3β (IC50 = 3,100 nM). It inhibits proliferation of TMD8 B cell lymphoma and 92.1 uveal melanoma cells (IC50s = 900 and 184 nM, respectively) but not SK-MEL-28 skin melanoma cells (IC50 = >10,000 nM).  

     

    Brand:
    Cayman
    SKU:31455 - 10 mg

    Available on backorder

  • LXS-196 is a PKC inhibitor (IC50s = 1.9 and 0.4 nM for PKCα and PKCθ, respectively).{52782} It is selective for PKCα and PKCθ over GSK3β (IC50 = 3,100 nM). It inhibits proliferation of TMD8 B cell lymphoma and 92.1 uveal melanoma cells (IC50s = 900 and 184 nM, respectively) but not SK-MEL-28 skin melanoma cells (IC50 = >10,000 nM).  

     

    Brand:
    Cayman
    SKU:31455 - 25 mg

    Available on backorder

  • LXS-196 is a PKC inhibitor (IC50s = 1.9 and 0.4 nM for PKCα and PKCθ, respectively).{52782} It is selective for PKCα and PKCθ over GSK3β (IC50 = 3,100 nM). It inhibits proliferation of TMD8 B cell lymphoma and 92.1 uveal melanoma cells (IC50s = 900 and 184 nM, respectively) but not SK-MEL-28 skin melanoma cells (IC50 = >10,000 nM).  

     

    Brand:
    Cayman
    SKU:31455 - 5 mg

    Available on backorder

  • LY171883 is a selective, potent, orally active antagonist of the leukotriene D4 receptor.{1741} Dissociation constants (KB) for LY171883 on guinea pig ileum and parenchyma are 0.07 and 0.34 µM, respectively.{1741} LY171883 is an inhibitor of phosphodiesterase obtained from human polymorphonuclear leukocytes (IC50 of 22.6 µM) and various guinea pig tissues (IC50s range from 6.9-209 µM).{1741} At a concentration of 50-100 µM, LY171883 binds to the PPARγ nuclear receptor, inducing adipogenesis in cultured NIH3T3 fibroblasts.{1618,1425}  

     

    Brand:
    Cayman
    SKU:70710 - 10 mg

    Available on backorder

  • LY171883 is a selective, potent, orally active antagonist of the leukotriene D4 receptor.{1741} Dissociation constants (KB) for LY171883 on guinea pig ileum and parenchyma are 0.07 and 0.34 µM, respectively.{1741} LY171883 is an inhibitor of phosphodiesterase obtained from human polymorphonuclear leukocytes (IC50 of 22.6 µM) and various guinea pig tissues (IC50s range from 6.9-209 µM).{1741} At a concentration of 50-100 µM, LY171883 binds to the PPARγ nuclear receptor, inducing adipogenesis in cultured NIH3T3 fibroblasts.{1618,1425}  

     

    Brand:
    Cayman
    SKU:70710 - 100 mg

    Available on backorder

  • LY171883 is a selective, potent, orally active antagonist of the leukotriene D4 receptor.{1741} Dissociation constants (KB) for LY171883 on guinea pig ileum and parenchyma are 0.07 and 0.34 µM, respectively.{1741} LY171883 is an inhibitor of phosphodiesterase obtained from human polymorphonuclear leukocytes (IC50 of 22.6 µM) and various guinea pig tissues (IC50s range from 6.9-209 µM).{1741} At a concentration of 50-100 µM, LY171883 binds to the PPARγ nuclear receptor, inducing adipogenesis in cultured NIH3T3 fibroblasts.{1618,1425}  

     

    Brand:
    Cayman
    SKU:70710 - 5 mg

    Available on backorder

  • LY171883 is a selective, potent, orally active antagonist of the leukotriene D4 receptor.{1741} Dissociation constants (KB) for LY171883 on guinea pig ileum and parenchyma are 0.07 and 0.34 µM, respectively.{1741} LY171883 is an inhibitor of phosphodiesterase obtained from human polymorphonuclear leukocytes (IC50 of 22.6 µM) and various guinea pig tissues (IC50s range from 6.9-209 µM).{1741} At a concentration of 50-100 µM, LY171883 binds to the PPARγ nuclear receptor, inducing adipogenesis in cultured NIH3T3 fibroblasts.{1618,1425}  

     

    Brand:
    Cayman
    SKU:70710 - 50 mg

    Available on backorder

  • LY2090314 is potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) with IC50 values of 1.5 and 0.9 nM for human recombinant GSK3α and GSK3β, respectively.{39184} It has >10-fold selectivity for GSK3 over a panel of 40 kinases at a concentration of 20 μM. LY2090314 induces time-dependent stabilization of β-catenin total protein and activates Wnt signaling in vitro. It has potent antiproliferative activity in BRAF wild-type/NRAS mutant and BRAF mutant melanoma cell lines (IC50s = 6.0-11.8 nM) but has limited to no activity in non-melanoma cell lines with (IC50s = 430 to >20,000 nM). Knockdown of β-catenin in A375 and M14 melanoma cells induces LY2090314 resistance in vitro, indicating that LY2090314-induced cell death is dependent upon Wnt activation. In vivo, LY2090314 reduces tumor volume in a murine A375 melanoma xenograft model as a single agent and synergizes with decabarzine for a greater antitumor effect. Formulations containing LY2090314 are under clinical investigation for the treatment of advanced solid tumors.{39185}  

     

    Brand:
    Cayman
    SKU:22211 -

    Out of stock

  • LY2090314 is potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) with IC50 values of 1.5 and 0.9 nM for human recombinant GSK3α and GSK3β, respectively.{39184} It has >10-fold selectivity for GSK3 over a panel of 40 kinases at a concentration of 20 μM. LY2090314 induces time-dependent stabilization of β-catenin total protein and activates Wnt signaling in vitro. It has potent antiproliferative activity in BRAF wild-type/NRAS mutant and BRAF mutant melanoma cell lines (IC50s = 6.0-11.8 nM) but has limited to no activity in non-melanoma cell lines with (IC50s = 430 to >20,000 nM). Knockdown of β-catenin in A375 and M14 melanoma cells induces LY2090314 resistance in vitro, indicating that LY2090314-induced cell death is dependent upon Wnt activation. In vivo, LY2090314 reduces tumor volume in a murine A375 melanoma xenograft model as a single agent and synergizes with decabarzine for a greater antitumor effect. Formulations containing LY2090314 are under clinical investigation for the treatment of advanced solid tumors.{39185}  

     

    Brand:
    Cayman
    SKU:22211 -

    Out of stock

  • LY2090314 is potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) with IC50 values of 1.5 and 0.9 nM for human recombinant GSK3α and GSK3β, respectively.{39184} It has >10-fold selectivity for GSK3 over a panel of 40 kinases at a concentration of 20 μM. LY2090314 induces time-dependent stabilization of β-catenin total protein and activates Wnt signaling in vitro. It has potent antiproliferative activity in BRAF wild-type/NRAS mutant and BRAF mutant melanoma cell lines (IC50s = 6.0-11.8 nM) but has limited to no activity in non-melanoma cell lines with (IC50s = 430 to >20,000 nM). Knockdown of β-catenin in A375 and M14 melanoma cells induces LY2090314 resistance in vitro, indicating that LY2090314-induced cell death is dependent upon Wnt activation. In vivo, LY2090314 reduces tumor volume in a murine A375 melanoma xenograft model as a single agent and synergizes with decabarzine for a greater antitumor effect. Formulations containing LY2090314 are under clinical investigation for the treatment of advanced solid tumors.{39185}  

     

    Brand:
    Cayman
    SKU:22211 -

    Out of stock

  • LY2090314 is potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) with IC50 values of 1.5 and 0.9 nM for human recombinant GSK3α and GSK3β, respectively.{39184} It has >10-fold selectivity for GSK3 over a panel of 40 kinases at a concentration of 20 μM. LY2090314 induces time-dependent stabilization of β-catenin total protein and activates Wnt signaling in vitro. It has potent antiproliferative activity in BRAF wild-type/NRAS mutant and BRAF mutant melanoma cell lines (IC50s = 6.0-11.8 nM) but has limited to no activity in non-melanoma cell lines with (IC50s = 430 to >20,000 nM). Knockdown of β-catenin in A375 and M14 melanoma cells induces LY2090314 resistance in vitro, indicating that LY2090314-induced cell death is dependent upon Wnt activation. In vivo, LY2090314 reduces tumor volume in a murine A375 melanoma xenograft model as a single agent and synergizes with decabarzine for a greater antitumor effect. Formulations containing LY2090314 are under clinical investigation for the treatment of advanced solid tumors.{39185}  

     

    Brand:
    Cayman
    SKU:22211 -

    Out of stock

  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1/type II kinases (IC50 = 69 nM).{25084} It has been used to study the role of TGF-β signaling in tumor cell migration and metastasis in pancreatic tumor cell lines where 5 μM of the compound completely disrupts Smad-2 phosphorylation, an immediate downstream target of the kinase activity.{25082} It can also suppress radiation-induced inflammatory cytokine signaling and proangiogenic genes, including ID1, in human primary fibrobalsts.{25083}  

     

    Brand:
    Cayman
    SKU:-
  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1/type II kinases (IC50 = 69 nM).{25084} It has been used to study the role of TGF-β signaling in tumor cell migration and metastasis in pancreatic tumor cell lines where 5 μM of the compound completely disrupts Smad-2 phosphorylation, an immediate downstream target of the kinase activity.{25082} It can also suppress radiation-induced inflammatory cytokine signaling and proangiogenic genes, including ID1, in human primary fibrobalsts.{25083}  

     

    Brand:
    Cayman
    SKU:-
  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1/type II kinases (IC50 = 69 nM).{25084} It has been used to study the role of TGF-β signaling in tumor cell migration and metastasis in pancreatic tumor cell lines where 5 μM of the compound completely disrupts Smad-2 phosphorylation, an immediate downstream target of the kinase activity.{25082} It can also suppress radiation-induced inflammatory cytokine signaling and proangiogenic genes, including ID1, in human primary fibrobalsts.{25083}  

     

    Brand:
    Cayman
    SKU:-
  • LY2119620 is a positive allosteric modulator of the M2 and M4 muscarinic acetylcholine receptors (mAChRs).{48128} It binds to allosteric sites on M2 and M4 receptors with KB values ranging from 1.8 to 3.4 μM. LY2119620 potentiates the activity of the AChR agonist acetylcholine (ACh; Item No. 23829) and the mAChR agonists iperoxo and oxotremorine M (Item No. 20847) at human recombinant M2 and M4 receptors expressed in CHO cell membranes. LY2119620 also exhibits allosteric agonism at M2 and M4 receptors (23.2 and 16.8%, respectively, of the maximal ACh response).  

     

    Brand:
    Cayman
    SKU:26373 - 1 mg

    Available on backorder

  • LY2119620 is a positive allosteric modulator of the M2 and M4 muscarinic acetylcholine receptors (mAChRs).{48128} It binds to allosteric sites on M2 and M4 receptors with KB values ranging from 1.8 to 3.4 μM. LY2119620 potentiates the activity of the AChR agonist acetylcholine (ACh; Item No. 23829) and the mAChR agonists iperoxo and oxotremorine M (Item No. 20847) at human recombinant M2 and M4 receptors expressed in CHO cell membranes. LY2119620 also exhibits allosteric agonism at M2 and M4 receptors (23.2 and 16.8%, respectively, of the maximal ACh response).  

     

    Brand:
    Cayman
    SKU:26373 - 10 mg

    Available on backorder

  • LY2119620 is a positive allosteric modulator of the M2 and M4 muscarinic acetylcholine receptors (mAChRs).{48128} It binds to allosteric sites on M2 and M4 receptors with KB values ranging from 1.8 to 3.4 μM. LY2119620 potentiates the activity of the AChR agonist acetylcholine (ACh; Item No. 23829) and the mAChR agonists iperoxo and oxotremorine M (Item No. 20847) at human recombinant M2 and M4 receptors expressed in CHO cell membranes. LY2119620 also exhibits allosteric agonism at M2 and M4 receptors (23.2 and 16.8%, respectively, of the maximal ACh response).  

     

    Brand:
    Cayman
    SKU:26373 - 5 mg

    Available on backorder

  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1 kinase (IC50 = 56 nM).{24957} It has been used to study the role of TGF-β signaling in chemotherapy-induced expansion of cancer stem-like cells in triple negative breast cancer cell lines and xenografts.{24958} LY2157299 has also been shown to inhibit the migration and tumor growth of hepatocellular carcinoma cell lines by disrupting Smad-2 phosphorylation.{24959}  

     

    Brand:
    Cayman
    SKU:-
  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1 kinase (IC50 = 56 nM).{24957} It has been used to study the role of TGF-β signaling in chemotherapy-induced expansion of cancer stem-like cells in triple negative breast cancer cell lines and xenografts.{24958} LY2157299 has also been shown to inhibit the migration and tumor growth of hepatocellular carcinoma cell lines by disrupting Smad-2 phosphorylation.{24959}  

     

    Brand:
    Cayman
    SKU:-
  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1 kinase (IC50 = 56 nM).{24957} It has been used to study the role of TGF-β signaling in chemotherapy-induced expansion of cancer stem-like cells in triple negative breast cancer cell lines and xenografts.{24958} LY2157299 has also been shown to inhibit the migration and tumor growth of hepatocellular carcinoma cell lines by disrupting Smad-2 phosphorylation.{24959}  

     

    Brand:
    Cayman
    SKU:-
  • LY2157299 is a small molecule inhibitor of the TGF-β receptor type 1 kinase (IC50 = 56 nM).{24957} It has been used to study the role of TGF-β signaling in chemotherapy-induced expansion of cancer stem-like cells in triple negative breast cancer cell lines and xenografts.{24958} LY2157299 has also been shown to inhibit the migration and tumor growth of hepatocellular carcinoma cell lines by disrupting Smad-2 phosphorylation.{24959}  

     

    Brand:
    Cayman
    SKU:-
  • LY2183240 is a potent, competitive inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.{14134,15431,16339} It increases anandamide levels in rat cerebellum (ED50 = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain.{14134}  

     

    Brand:
    Cayman
    SKU:10008663 - 1 mg

    Available on backorder

  • LY2183240 is a potent, competitive inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.{14134,15431,16339} It increases anandamide levels in rat cerebellum (ED50 = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain.{14134}  

     

    Brand:
    Cayman
    SKU:10008663 - 5 mg

    Available on backorder

  • LY2183240 (Item No. 10008663) is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.{14134,15431,16339} It has been shown to increase anandamide levels in rat cerebellum (ED50 = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain.{14134} LY2183240 2’-isomer is a less potent, 2,5-regioisomer of LY2183240 that inhibits anandamide hydrolysis and uptake with IC50 values of 33 and 998 nM, respectively.{15431}  

     

    Brand:
    Cayman
    SKU:-
  • LY2183240 (Item No. 10008663) is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.{14134,15431,16339} It has been shown to increase anandamide levels in rat cerebellum (ED50 = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain.{14134} LY2183240 2’-isomer is a less potent, 2,5-regioisomer of LY2183240 that inhibits anandamide hydrolysis and uptake with IC50 values of 33 and 998 nM, respectively.{15431}  

     

    Brand:
    Cayman
    SKU:-
  • LY2183240 (Item No. 10008663) is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.{14134,15431,16339} It has been shown to increase anandamide levels in rat cerebellum (ED50 = 1.37 mg/kg) and displays dose-dependent efficacy (3-30 mg/kg) in several rodent models of persistent pain.{14134} LY2183240 2’-isomer is a less potent, 2,5-regioisomer of LY2183240 that inhibits anandamide hydrolysis and uptake with IC50 values of 33 and 998 nM, respectively.{15431}  

     

    Brand:
    Cayman
    SKU:-
  • LY2228820 is a potent inhibitor of p38α MAP kinase (IC50 = 7 nM for human recombinant p38α).{39389} It inhibits LPS-induced TNF-α production in murine peritoneal macrophages and reduces phosphorylation of MAPKAPK-2 (MK2) in RAW 264.7 cells (IC50s = 5.2 and 34.3 nM, respectively). LY2228820 inhibits TNF-α production in LPS-treated mice and reduces paw swelling and cartilage destruction in a rat model of chronic inflammation with threshold minimum 50% doses (TMED50) values of <1, 1.5, and 1.5 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:23259 - 1 mg

    Available on backorder

  • LY2228820 is a potent inhibitor of p38α MAP kinase (IC50 = 7 nM for human recombinant p38α).{39389} It inhibits LPS-induced TNF-α production in murine peritoneal macrophages and reduces phosphorylation of MAPKAPK-2 (MK2) in RAW 264.7 cells (IC50s = 5.2 and 34.3 nM, respectively). LY2228820 inhibits TNF-α production in LPS-treated mice and reduces paw swelling and cartilage destruction in a rat model of chronic inflammation with threshold minimum 50% doses (TMED50) values of <1, 1.5, and 1.5 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:23259 - 10 mg

    Available on backorder

  • LY2228820 is a potent inhibitor of p38α MAP kinase (IC50 = 7 nM for human recombinant p38α).{39389} It inhibits LPS-induced TNF-α production in murine peritoneal macrophages and reduces phosphorylation of MAPKAPK-2 (MK2) in RAW 264.7 cells (IC50s = 5.2 and 34.3 nM, respectively). LY2228820 inhibits TNF-α production in LPS-treated mice and reduces paw swelling and cartilage destruction in a rat model of chronic inflammation with threshold minimum 50% doses (TMED50) values of <1, 1.5, and 1.5 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:23259 - 25 mg

    Available on backorder

  • LY2228820 is a potent inhibitor of p38α MAP kinase (IC50 = 7 nM for human recombinant p38α).{39389} It inhibits LPS-induced TNF-α production in murine peritoneal macrophages and reduces phosphorylation of MAPKAPK-2 (MK2) in RAW 264.7 cells (IC50s = 5.2 and 34.3 nM, respectively). LY2228820 inhibits TNF-α production in LPS-treated mice and reduces paw swelling and cartilage destruction in a rat model of chronic inflammation with threshold minimum 50% doses (TMED50) values of <1, 1.5, and 1.5 mg/kg, respectively.  

     

    Brand:
    Cayman
    SKU:23259 - 5 mg

    Available on backorder

  • Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. The benzophenone dicarboxylic acid derivative LY223982 is a potent BLT1 receptor antagonist. It inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 13.2 nM.{16067} LY223982 inhibits the leukotriene B4 (LTB4)-induced aggregation of guinea pig and human neutrophils with IC50 values of 74 and 100 nM, respectively.{16065} However, concentrations of LY223982 up to 10 µM do not inhibit binding of LTB4 to human BLT1 or BLT2 expressed in CHO cells.{9270}  

     

    Brand:
    Cayman
    SKU:10010024 - 1 mg

    Available on backorder

  • Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. The benzophenone dicarboxylic acid derivative LY223982 is a potent BLT1 receptor antagonist. It inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 13.2 nM.{16067} LY223982 inhibits the leukotriene B4 (LTB4)-induced aggregation of guinea pig and human neutrophils with IC50 values of 74 and 100 nM, respectively.{16065} However, concentrations of LY223982 up to 10 µM do not inhibit binding of LTB4 to human BLT1 or BLT2 expressed in CHO cells.{9270}  

     

    Brand:
    Cayman
    SKU:10010024 - 10 mg

    Available on backorder

  • Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. The benzophenone dicarboxylic acid derivative LY223982 is a potent BLT1 receptor antagonist. It inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 13.2 nM.{16067} LY223982 inhibits the leukotriene B4 (LTB4)-induced aggregation of guinea pig and human neutrophils with IC50 values of 74 and 100 nM, respectively.{16065} However, concentrations of LY223982 up to 10 µM do not inhibit binding of LTB4 to human BLT1 or BLT2 expressed in CHO cells.{9270}  

     

    Brand:
    Cayman
    SKU:10010024 - 25 mg

    Available on backorder

  • Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from the 5-lipoxygenase pathway of arachidonic acid metabolism and is an important mediator of the inflammatory process. The benzophenone dicarboxylic acid derivative LY223982 is a potent BLT1 receptor antagonist. It inhibits the specific binding of radiolabeled-LTB4 to isolated human neutrophils with an IC50 value of 13.2 nM.{16067} LY223982 inhibits the leukotriene B4 (LTB4)-induced aggregation of guinea pig and human neutrophils with IC50 values of 74 and 100 nM, respectively.{16065} However, concentrations of LY223982 up to 10 µM do not inhibit binding of LTB4 to human BLT1 or BLT2 expressed in CHO cells.{9270}  

     

    Brand:
    Cayman
    SKU:10010024 - 5 mg

    Available on backorder

  • LY2409881 is a selective inhibitor of IκB kinase β (IKK2; IC50 = 30 nM).{32487} It inhibits IKK1 and other common kinases at ≥10-fold higher concentrations.{32487} LY2409881 has been shown to suppress constitutively activated NF-κB and to induce apoptosis in lymphoma cells both in vitro and in preclinical mouse models of B and T cell lymphoma both as a single agent and in combination with histone deacetylase inhibitors.{32487}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • LY2409881 is a selective inhibitor of IκB kinase β (IKK2; IC50 = 30 nM).{32487} It inhibits IKK1 and other common kinases at ≥10-fold higher concentrations.{32487} LY2409881 has been shown to suppress constitutively activated NF-κB and to induce apoptosis in lymphoma cells both in vitro and in preclinical mouse models of B and T cell lymphoma both as a single agent and in combination with histone deacetylase inhibitors.{32487}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • LY2409881 is a selective inhibitor of IκB kinase β (IKK2; IC50 = 30 nM).{32487} It inhibits IKK1 and other common kinases at ≥10-fold higher concentrations.{32487} LY2409881 has been shown to suppress constitutively activated NF-κB and to induce apoptosis in lymphoma cells both in vitro and in preclinical mouse models of B and T cell lymphoma both as a single agent and in combination with histone deacetylase inhibitors.{32487}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • LY2409881 is a selective inhibitor of IκB kinase β (IKK2; IC50 = 30 nM).{32487} It inhibits IKK1 and other common kinases at ≥10-fold higher concentrations.{32487} LY2409881 has been shown to suppress constitutively activated NF-κB and to induce apoptosis in lymphoma cells both in vitro and in preclinical mouse models of B and T cell lymphoma both as a single agent and in combination with histone deacetylase inhibitors.{32487}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years.{4552,4553} The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM.{2084} LY255283 exhibits IC50 values of ~950 nM and >10 µM at human recombinant BLT2 and BLT1 receptors, respectively.{9270} LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 µM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.{4552}  

     

    Brand:
    Cayman
    SKU:70715 - 1 mg

    Available on backorder

  • Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years.{4552,4553} The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM.{2084} LY255283 exhibits IC50 values of ~950 nM and >10 µM at human recombinant BLT2 and BLT1 receptors, respectively.{9270} LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 µM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.{4552}  

     

    Brand:
    Cayman
    SKU:70715 - 10 mg

    Available on backorder

  • Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years.{4552,4553} The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM.{2084} LY255283 exhibits IC50 values of ~950 nM and >10 µM at human recombinant BLT2 and BLT1 receptors, respectively.{9270} LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 µM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.{4552}  

     

    Brand:
    Cayman
    SKU:70715 - 25 mg

    Available on backorder

  • Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years.{4552,4553} The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM.{2084} LY255283 exhibits IC50 values of ~950 nM and >10 µM at human recombinant BLT2 and BLT1 receptors, respectively.{9270} LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 µM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.{4552}  

     

    Brand:
    Cayman
    SKU:70715 - 5 mg

    Available on backorder

  • LY2562175 is a farnesoid X receptor (FXR) agonist (EC50 = 193 nM in a reporter assay).{48622} It is selective for FXR over the glucocorticoid, androgen, mineralocorticoid, and progesterone receptors in HEK293 cells overexpressing the human receptors (EC50s = >10 µM for all in a radioligand binding assay). LY2562175 increases the interaction between FXR and steroid receptor coactivator 1 (SRC-1) with an EC50 value of 121 nM in a cell-free assay. It reduces plasma triglyceride and total cholesterol levels in LDL receptor-null mice (ED50s = 3.4 and 2 mg/kg, respectively). LY2562175 also decreases plasma LDL and increases HDL levels in Zucker diabetic fatty (ZDF) rats when administered at doses of 3, 10, and 30 mg/kg for nine days.  

     

    Brand:
    Cayman
    SKU:28912 - 1 mg

    Available on backorder

  • LY2562175 is a farnesoid X receptor (FXR) agonist (EC50 = 193 nM in a reporter assay).{48622} It is selective for FXR over the glucocorticoid, androgen, mineralocorticoid, and progesterone receptors in HEK293 cells overexpressing the human receptors (EC50s = >10 µM for all in a radioligand binding assay). LY2562175 increases the interaction between FXR and steroid receptor coactivator 1 (SRC-1) with an EC50 value of 121 nM in a cell-free assay. It reduces plasma triglyceride and total cholesterol levels in LDL receptor-null mice (ED50s = 3.4 and 2 mg/kg, respectively). LY2562175 also decreases plasma LDL and increases HDL levels in Zucker diabetic fatty (ZDF) rats when administered at doses of 3, 10, and 30 mg/kg for nine days.  

     

    Brand:
    Cayman
    SKU:28912 - 10 mg

    Available on backorder

  • LY2562175 is a farnesoid X receptor (FXR) agonist (EC50 = 193 nM in a reporter assay).{48622} It is selective for FXR over the glucocorticoid, androgen, mineralocorticoid, and progesterone receptors in HEK293 cells overexpressing the human receptors (EC50s = >10 µM for all in a radioligand binding assay). LY2562175 increases the interaction between FXR and steroid receptor coactivator 1 (SRC-1) with an EC50 value of 121 nM in a cell-free assay. It reduces plasma triglyceride and total cholesterol levels in LDL receptor-null mice (ED50s = 3.4 and 2 mg/kg, respectively). LY2562175 also decreases plasma LDL and increases HDL levels in Zucker diabetic fatty (ZDF) rats when administered at doses of 3, 10, and 30 mg/kg for nine days.  

     

    Brand:
    Cayman
    SKU:28912 - 25 mg

    Available on backorder

  • LY2562175 is a farnesoid X receptor (FXR) agonist (EC50 = 193 nM in a reporter assay).{48622} It is selective for FXR over the glucocorticoid, androgen, mineralocorticoid, and progesterone receptors in HEK293 cells overexpressing the human receptors (EC50s = >10 µM for all in a radioligand binding assay). LY2562175 increases the interaction between FXR and steroid receptor coactivator 1 (SRC-1) with an EC50 value of 121 nM in a cell-free assay. It reduces plasma triglyceride and total cholesterol levels in LDL receptor-null mice (ED50s = 3.4 and 2 mg/kg, respectively). LY2562175 also decreases plasma LDL and increases HDL levels in Zucker diabetic fatty (ZDF) rats when administered at doses of 3, 10, and 30 mg/kg for nine days.  

     

    Brand:
    Cayman
    SKU:28912 - 5 mg

    Available on backorder

  • p70 Ribosomal S6 kinase (p70S6K) is a serine/threonine kinase that is activated by insulin and growth factors through PI3K and mTORC1 signaling pathways. LY2584702 is a selective, cell-permeable p70S6K inhibitor (IC50 = 4 nM). It blocks phosphorylation of p70S6K in primary rat hepatocytes without affecting the phosphorylation of other signaling kinases, including GSK-3β and ERK1/2.{30510} LY2584702 inhibits phosphorylation of p70S6K in HCT116 colon cancer cells (IC50 = 0.1-0.24 μM in vitro) and demonstrates significant antitumor efficacy in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models.{30512} It also reverses the effects of mTORC1 hyperactivation on triglyceride metabolism in human hepatoma cells.{30511} LY2584702, alone or in combination with the mTOR inhibitor everolimus (Item No. 11597), has been evaluated in clinical trials against solid tumors.{30512,30509}  

     

    Brand:
    Cayman
    SKU:-
  • p70 Ribosomal S6 kinase (p70S6K) is a serine/threonine kinase that is activated by insulin and growth factors through PI3K and mTORC1 signaling pathways. LY2584702 is a selective, cell-permeable p70S6K inhibitor (IC50 = 4 nM). It blocks phosphorylation of p70S6K in primary rat hepatocytes without affecting the phosphorylation of other signaling kinases, including GSK-3β and ERK1/2.{30510} LY2584702 inhibits phosphorylation of p70S6K in HCT116 colon cancer cells (IC50 = 0.1-0.24 μM in vitro) and demonstrates significant antitumor efficacy in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models.{30512} It also reverses the effects of mTORC1 hyperactivation on triglyceride metabolism in human hepatoma cells.{30511} LY2584702, alone or in combination with the mTOR inhibitor everolimus (Item No. 11597), has been evaluated in clinical trials against solid tumors.{30512,30509}  

     

    Brand:
    Cayman
    SKU:-
  • p70 Ribosomal S6 kinase (p70S6K) is a serine/threonine kinase that is activated by insulin and growth factors through PI3K and mTORC1 signaling pathways. LY2584702 is a selective, cell-permeable p70S6K inhibitor (IC50 = 4 nM). It blocks phosphorylation of p70S6K in primary rat hepatocytes without affecting the phosphorylation of other signaling kinases, including GSK-3β and ERK1/2.{30510} LY2584702 inhibits phosphorylation of p70S6K in HCT116 colon cancer cells (IC50 = 0.1-0.24 μM in vitro) and demonstrates significant antitumor efficacy in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models.{30512} It also reverses the effects of mTORC1 hyperactivation on triglyceride metabolism in human hepatoma cells.{30511} LY2584702, alone or in combination with the mTOR inhibitor everolimus (Item No. 11597), has been evaluated in clinical trials against solid tumors.{30512,30509}  

     

    Brand:
    Cayman
    SKU:-
  • p70 Ribosomal S6 kinase (p70S6K) is a serine/threonine kinase that is activated by insulin and growth factors through PI3K and mTORC1 signaling pathways. LY2584702 is a selective, cell-permeable p70S6K inhibitor (IC50 = 4 nM). It blocks phosphorylation of p70S6K in primary rat hepatocytes without affecting the phosphorylation of other signaling kinases, including GSK-3β and ERK1/2.{30510} LY2584702 inhibits phosphorylation of p70S6K in HCT116 colon cancer cells (IC50 = 0.1-0.24 μM in vitro) and demonstrates significant antitumor efficacy in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models.{30512} It also reverses the effects of mTORC1 hyperactivation on triglyceride metabolism in human hepatoma cells.{30511} LY2584702, alone or in combination with the mTOR inhibitor everolimus (Item No. 11597), has been evaluated in clinical trials against solid tumors.{30512,30509}  

     

    Brand:
    Cayman
    SKU:-
  • LY2603618 is a checkpoint kinase 1 (Chk1) inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by DNA-damaging agents.{32250} It can inhibit Chk1 autophosphorylation and increase DNA damage-mediated Chk1 phosphorylation.{32251} LY2603618 has been used in xenograft tumor models to potentiate the antitumor efficacy of chemotherapeutic agents such as gemcitabine (Item No. 11690).{32249}  

     

    Brand:
    Cayman
    SKU:20351 -

    Available on backorder

  • LY2603618 is a checkpoint kinase 1 (Chk1) inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by DNA-damaging agents.{32250} It can inhibit Chk1 autophosphorylation and increase DNA damage-mediated Chk1 phosphorylation.{32251} LY2603618 has been used in xenograft tumor models to potentiate the antitumor efficacy of chemotherapeutic agents such as gemcitabine (Item No. 11690).{32249}  

     

    Brand:
    Cayman
    SKU:20351 -

    Available on backorder

  • LY2603618 is a checkpoint kinase 1 (Chk1) inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by DNA-damaging agents.{32250} It can inhibit Chk1 autophosphorylation and increase DNA damage-mediated Chk1 phosphorylation.{32251} LY2603618 has been used in xenograft tumor models to potentiate the antitumor efficacy of chemotherapeutic agents such as gemcitabine (Item No. 11690).{32249}  

     

    Brand:
    Cayman
    SKU:20351 -

    Available on backorder

  • LY2603618 is a checkpoint kinase 1 (Chk1) inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by DNA-damaging agents.{32250} It can inhibit Chk1 autophosphorylation and increase DNA damage-mediated Chk1 phosphorylation.{32251} LY2603618 has been used in xenograft tumor models to potentiate the antitumor efficacy of chemotherapeutic agents such as gemcitabine (Item No. 11690).{32249}  

     

    Brand:
    Cayman
    SKU:20351 -

    Available on backorder

  • LY2606368 is a checkpoint kinase 1 (Chk1) inhibitor with a Ki value of 0.9 nM against the purified target and IC50 values of In vitro, LY2606368 inhibits the doxorubicin-activated G2/M checkpoint in p53-deficient HeLa cells with an EC50 value of 9 nM.{34611} LY2606368, at 25 nM, also significantly induces apoptosis and inhibits colony formation in AGS and MKN1 gastric cancer cells.{34613}  

     

    Brand:
    Cayman
    SKU:21490 -

    Out of stock

  • LY2606368 is a checkpoint kinase 1 (Chk1) inhibitor with a Ki value of 0.9 nM against the purified target and IC50 values of In vitro, LY2606368 inhibits the doxorubicin-activated G2/M checkpoint in p53-deficient HeLa cells with an EC50 value of 9 nM.{34611} LY2606368, at 25 nM, also significantly induces apoptosis and inhibits colony formation in AGS and MKN1 gastric cancer cells.{34613}  

     

    Brand:
    Cayman
    SKU:21490 -

    Out of stock

  • LY2606368 is a checkpoint kinase 1 (Chk1) inhibitor with a Ki value of 0.9 nM against the purified target and IC50 values of In vitro, LY2606368 inhibits the doxorubicin-activated G2/M checkpoint in p53-deficient HeLa cells with an EC50 value of 9 nM.{34611} LY2606368, at 25 nM, also significantly induces apoptosis and inhibits colony formation in AGS and MKN1 gastric cancer cells.{34613}  

     

    Brand:
    Cayman
    SKU:21490 -

    Out of stock

  • LY2606368 is a checkpoint kinase 1 (Chk1) inhibitor with a Ki value of 0.9 nM against the purified target and IC50 values of In vitro, LY2606368 inhibits the doxorubicin-activated G2/M checkpoint in p53-deficient HeLa cells with an EC50 value of 9 nM.{34611} LY2606368, at 25 nM, also significantly induces apoptosis and inhibits colony formation in AGS and MKN1 gastric cancer cells.{34613}  

     

    Brand:
    Cayman
    SKU:21490 -

    Out of stock

  • LY2608204 is an activator of glucokinase (GK; EC50 = 42 nM).{41671} It stimulates glucose metabolism in INS-1E rat insulinoma cells (mean EC50 = 579 nM). LY2608204 (30 mg/kg) decreases plasma glucose levels in a dose-dependent manner in fasted rats.  

     

    Brand:
    Cayman
    SKU:22914 - 1 mg

    Available on backorder

  • LY2608204 is an activator of glucokinase (GK; EC50 = 42 nM).{41671} It stimulates glucose metabolism in INS-1E rat insulinoma cells (mean EC50 = 579 nM). LY2608204 (30 mg/kg) decreases plasma glucose levels in a dose-dependent manner in fasted rats.  

     

    Brand:
    Cayman
    SKU:22914 - 10 mg

    Available on backorder

  • LY2608204 is an activator of glucokinase (GK; EC50 = 42 nM).{41671} It stimulates glucose metabolism in INS-1E rat insulinoma cells (mean EC50 = 579 nM). LY2608204 (30 mg/kg) decreases plasma glucose levels in a dose-dependent manner in fasted rats.  

     

    Brand:
    Cayman
    SKU:22914 - 25 mg

    Available on backorder